Keywords: GlaxoSmithKline, Synforix, GAVI Alliance, Pakistan, Pneumococcal vaccines program

GSK's Synflorix to be used for GAVI pneumococcal vaccines program in Pakistan

Article | 10 October 2012

Print This

World’s largest pneumococcal mass vaccination program is expected to protect up to 4.8 million children in Pakistan from pneumococcal ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in